Metabolic bariatric surgery is associated with reduced adverse hepatic and extrahepatic outcomes, and lower all-cause mortality, in patients with steatotic liver disease.

In male patients and those without additional metabolic risk factors, the HR did not reach statistical significance (Males: 0.79 (0.61–1.02), No‐T2D: 1.01 (0.80–1.28); BMI < 50 kg/m 2 : 0.89 (0.77–1.02), Figure 3 , Tables S19–26 and Figures S2–S5 ).

also in 111,027 other papers